| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -50.8% | -58.0% |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 3.8 | 3.3 |
| Pr/Book | 1.4 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 34.8% | 16.2% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 1.37 | (2.55) | (0.66)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 1.23 | (3.40) | (0.73)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 1.83 | (2.57) | (0.59)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 3.19 | (6.92) | (1.54)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 4.30 | (2.18) | (0.36)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 5.00 | (2.90) | (0.43)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-26 | 6.10 | (1.50) | (0.23)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Mevalone Label Extension in France | 07-Jan-2026 | 07:00 | RNS |
| Appointment of Syngenta as Distribution Partner | 18-Dec-2025 | 07:00 | RNS |
| 3LOGY Label Extension in Italy | 20-Nov-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 3.05p |
| Change Today | -0.050p |
| % Change | -1.61 % |
| 52 Week High | 4.25p |
| 52 Week Low | 2.10p |
| Volume | 660,430 |
| Shares Issued | 533.35m |
| Market Cap | £16.27m |
| Beta | 0.81 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:43 | 14,062 @ 3.20p |
| 14:23 | 65,324 @ 3.08p |
| 13:39 | 1,377 @ 3.20p |
| 13:35 | 7,577 @ 2.90p |
| 13:35 | 1,875 @ 3.20p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research